Ipilimumab/nivolumabHypopituitarism, meningoencephalitis and hypophysitis: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1919卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21272-8

中图分类号：

学科分类号：

摘要：

引用

页码：330 / 330

共 50 条

[31] Ipilimumab/NivolumabHyperthyroidism and hypophysitis
Reactions Weekly, 2024, 2006 (1) : 342 - 342
[32] Ipilimumab/nivolumab/pembrolizumabVitiligo and hypophysitis: 7 case reports
Reactions Weekly, 2020, 1795 (1) : 166 - 166
[33] Ipilimumab/nivolumabHyperthyroidism, hypothyroidism and hypophysitis : 9 case reports
Reactions Weekly, 2017, 1680 (1) : 191 - 191
[34] Ipilimumab/NivolumabDiabetes and hypophysitis
Reactions Weekly, 2023, 1984 (1) : 281 - 281
[35] Ipilimumab-Induced Hypophysitis May Not Affect All Pituitary Cell Lines: A Case Report
Kotwal, Anupam
Rao, Sarika
Haas, Richard Allen
JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 5 (05) : 299 - 303
[36] Hypophysitis induced by ipilimumab and nivolumab combination therapy for advanced renal cell carcinoma: A case report
Motonaga, Aoi
Nakanishi, Shotaro
Tanaka, Kei
Nishida, Sho
Izumi, Keiichiro
Saito, Seiichi
UROLOGY CASE REPORTS, 2021, 38
[37] NivolumabHypopituitarism leading to adrenal insufficiency: case report
Reactions Weekly, 2019, 1781 (1) : 269 - 269
[38] NAVIGATING HYPOPHYSITIS IN THE WAKE OF IMMUNOTHERAPY: A DUAL-AGENT PERSPECTIVE WITH PEMBROLIZUMAB AND IPILIMUMAB: A CASE REPORT
Naeem, Ammad
Kamran, Amir
Sebastian, William
Omar, Khawaja O.
CHEST, 2024, 166 (04) : 3156A - 3157A
[39] Ipilimumab/nivolumabAggravation of hypophysitis and inflammatory myopathy: 2 case reports
Reactions Weekly, 2020, 1785 (1) : 295 - 295
[40] Ipilimumab/nivolumabColitis, meningoencephalitis and thyroiditis: 2 case reports
Reactions Weekly, 2022, 1930 (1) : 316 - 316

← 1 2 3 4 5 →